ClearOne Gets Nasdaq Delisting Notice Over $2.5M Equity Rule

What happened

ClearOne, Inc. (Nasdaq: CLRO) said in a Form 8-K filed October 13, 2026 that it received a determination letter from Nasdaq's Listing Qualifications staff on October 8, 2026. The staff concluded that ClearOne had not demonstrated compliance with the $2,500,000 minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market, and determined to delist the company's securities.

The filing traces the issue to April 7, 2026, when Nasdaq first notified ClearOne that it no longer met the continued listing requirements of Nasdaq Listing Rule 5550(b). ClearOne had 45 days, until May 22, 2026, to submit a plan to regain compliance, and Nasdaq granted an exception of up to 180 days from April 7, 2026, or until October 5, 2026, to complete it.

According to the filing, the October 8 determination followed ClearOne's failure to complete the remedial actions described in the compliance plan it submitted on May 22, 2026.

ClearOne shares closed at $3.84 on the day of the filing, down 7.02% from the previous close of $4.13, according to the price data.

The appeal

ClearOne said it intends to timely request a hearing before a Nasdaq Hearings Panel by October 15, 2026, to appeal the staff's determination. The company said the hearing request will automatically stay any suspension or delisting action pending the hearing and the expiration of any additional extension period the Panel grants afterward. At the hearing, ClearOne said it intends to present its plan to regain compliance with the stockholders' equity rule.

The filing states that unless the company timely requests a hearing, trading in ClearOne's common stock will be suspended at the opening of business on October 19, 2026.

ClearOne is based in West Jordan, Utah, and its common stock trades on the Nasdaq Capital Market under the symbol CLRO.

What this means

A Form 8-K is a current report that a US-listed company files with the SEC when certain material events occur, in this case two items: Item 3.01, covering delisting notices and listing-rule failures, and Item 9.01, covering exhibits. Filing the form is how ClearOne satisfies its obligation to disclose the Nasdaq determination to the public rather than only to regulators.

The rule at issue, Nasdaq Listing Rule 5550(b)(1), requires a company on the Nasdaq Capital Market to maintain at least $2,500,000 in stockholders' equity — the difference between what a company owns and what it owes, and effectively the accounting measure of its net worth. A company that falls below that threshold is not removed immediately. Under Nasdaq's process, it is notified, given a set period to submit a written plan to regain compliance, and then granted an exception period, here running from April 7 to October 5, 2026, to carry out that plan. ClearOne did not complete the plan's remedial actions by that deadline, according to the filing, which is what triggered the October 8 delisting determination.

A delisting determination is not a removal that happens the same day. The company can request a hearing before a Nasdaq Hearings Panel; asking for the hearing freezes any suspension or delisting while the appeal proceeds. The most immediate date in the filing is October 15, 2026 — the deadline to request the hearing. If no hearing is requested in time, the stock would be suspended at the opening of business on October 19, 2026, and no longer trade on Nasdaq.

The filing does not state what specific steps ClearOne planned to take to restore its stockholders' equity, and it does not state the amount or cause of the shortfall. It also does not guarantee the outcome: ClearOne said there can be no assurance that Nasdaq will grant the hearing request or that the company will ultimately regain compliance with all applicable listing requirements.